You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients - calculated sample size: 1816 patients
|
|---|---|
| Published in |
BMC Infectious Diseases, April 2013
|
| DOI | 10.1186/1471-2334-13-178 |
| Pubmed ID | |
| Authors |
Evelien Assink-de Jong, Dylan W de Lange, Jos A van Oers, Maarten W Nijsten, Jos W Twisk, Albertus Beishuizen |
| Abstract |
Unnecessary long-term use of broad-spectrum antibiotics is linked to the emergence and selection of resistant bacteria, prolonged hospitalisation and increased costs. Several clinical trials indicate that the biomarker procalcitonin (PCT) can guide antibiotic therapy. Some of these trials have shown a promising reduction in the number of antibiotic prescriptions, duration of antibiotic therapy and even length of stay in the ICU, although their size and selection criteria limit their external validity. The objectives of the Stop Antibiotics on guidance of Procalcitonin Study (SAPS) are to evaluate whether daily PCT can improve "real-life" antibiotic use in Dutch ICU's by reduction of the duration of antibiotic treatment without an increase of recurrent infections and mortality. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 25% |
| Netherlands | 1 | 25% |
| France | 1 | 25% |
| Unknown | 1 | 25% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 238 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | <1% |
| Brazil | 1 | <1% |
| Indonesia | 1 | <1% |
| Japan | 1 | <1% |
| United Kingdom | 1 | <1% |
| Unknown | 232 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 34 | 14% |
| Student > Master | 32 | 13% |
| Other | 23 | 10% |
| Student > Ph. D. Student | 22 | 9% |
| Student > Doctoral Student | 19 | 8% |
| Other | 51 | 21% |
| Unknown | 57 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 108 | 45% |
| Pharmacology, Toxicology and Pharmaceutical Science | 15 | 6% |
| Immunology and Microbiology | 7 | 3% |
| Biochemistry, Genetics and Molecular Biology | 6 | 3% |
| Social Sciences | 5 | 2% |
| Other | 29 | 12% |
| Unknown | 68 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 July 2019.
All research outputs
#15,140,949
of 24,482,039 outputs
Outputs from BMC Infectious Diseases
#3,890
of 8,186 outputs
Outputs of similar age
#101,913
of 178,622 outputs
Outputs of similar age from BMC Infectious Diseases
#71
of 140 outputs
Altmetric has tracked 24,482,039 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,186 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.5. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 178,622 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 140 others from the same source and published within six weeks on either side of this one. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.